Pharmacokinetic patent...!!! (In Detail)
Adams Respiratory Therapeutics versus Perrigo - construction of the pharmacokinetic claim in terms of Cmax
- A company named Adams Respiratory Therapeutics holds a patent number (5, 372, 252,) and this patent covers an ER formulation that contains guaifenesin (it is an expectorant which is used to thin, loosen, and help to expel the mucus which causes congestion).
- Perrigo tried for the FDA approval for a generic of Adams' product, Mucinex(r).